Evaluation of PKU Sphere Liquid
NCT05096988 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2024-02-16
Summary
PKU Sphere Liquid is a prospective, open-label, acceptability study to evaluate PKU sphere liquid in up to 15 participants aged 3 and above for the dietary management of PKU over 31 days.
Conditions
- Phenylketonurias
Interventions
- DIETARY_SUPPLEMENT
-
PKU sphere liquid
PKU sphere liquid will be prescribed by the study dietitian based on the patient's individual requirements.
Sponsors & Collaborators
-
Vitaflo International, Ltd
lead INDUSTRY
Principal Investigators
-
Anita Macdonald · Birmingham Women's and Children's NHS Foundation Trust
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-23
- Primary Completion
- 2022-06-21
- Completion
- 2023-02-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia
NCT03167697 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute.
NCT05487378 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Low Phenylalanine Formulas
NCT06332105 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU)
NCT03777826 ·Status: COMPLETED ·Phase: NA
-
A Prospective Clinical Study of Phenylketonuria (PKU)
NCT04452513 ·Status: COMPLETED
-
Antioxidant Signature in Adult Patients With Phenylketonuria
NCT02212288 ·Status: COMPLETED
-
A Long-Term Study of JNT-517 in Participants With Phenylketonuria
NCT06628128 ·Status: RECRUITING ·Phase: PHASE3
-
Phenylketonuria, Oxidative Stress, and BH4
NCT01395394 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU)
NCT04085666 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
NCT05270837 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients
NCT04256655 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
NCT00634660 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
NCT06971731 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects
NCT06687733 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU)
NCT06629987 ·Status: COMPLETED
-
Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
NCT03694353 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
NCT01212744 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors
NCT00728676 ·Status: COMPLETED
-
Study of a National Cohort of Adult Patients With Phenylketonuria
NCT01619722 ·Status: COMPLETED
-
Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
NCT00841100 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria
NCT05972629 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
NCT05485987 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
NCT05166161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
AAV Gene Therapy Study for Subjects with PKU
NCT04480567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2